Antimicrobial potency and selectivity of simplified symmetric-end peptides

Because antimicrobial peptides (AMPs) are potentially useful for the treatment of multidrug-resistant infections, more attention is being paid to the structural modification and structure function relationship of both naturally occurring and synthetic AMPs. Previous studies indicated that Protegrin-1 (PG-1), isolated from porcine leukocytes, exhibited considerable antimicrobial activity and cytotoxicity. The 3-turn of PG-1 floated on the surface of bacterial membrane, while its beta-strand inserted into the bacterial membrane and formed pores that were dedicated to producing cytotoxicity. For reducing cytotoxicity and improving cells selectivity, we designed a series of simplified symmetric-end peptides by combining the beta-turn of PG-1 with simple amino acid repeat sequences. The sequence of designed symmetric-end peptides is (XR)(n)H(RX)(n), (n = 1,2; X represents I, F, W and P; H represents CRRRFC). The symmetric-end peptides displayed antimicrobial activity against both gram-positive and gram-negative bacteria. In particular, (XR)(2)H(RX)(2) (X here is I,F and W) showed greater antimicrobial potency than PG-1. Hemolysis activity and cytotoxicity, detected by using human red blood cells (RBCs) and human embryonic lung fibroblasts MRC-5 cells, were observably lower than the native peptide PG-1. (IR)(2)H(RI)(2) (IR2), folded into beta-sheet structures, displayed the highest therapeutic index, suggesting its great cell selectivity. The fluorescence spectroscopy, flow cytometry, and electron microscopy observation indicated that IR2 exhibited great membrane penetration potential by inducing membrane blebbing, disruption and lysis. Collectively, generating symmetric-end beta-sheet peptides is a promising strategy for designing effective AMPs with great antimicrobial activities and cell selectivity. (C) 2014 Elsevier Ltd. All rights reserved.